NCT04947683View on ClinicalTrials.gov

Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

April 6, 2020

Primary Completion Date

February 14, 2023

Study Completion Date

March 3, 2023

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (5)

Unknown

Centro Regional Integrado de Oncologia (CRIO), Fortaleza

Instituto D'OR, Rio de Janeiro

CPO Pucrs, Porto Alegre

59075-740

Liga Norte Riograndense Contra o Câncer, Natal

01525-001

A.C Camargo Cancer Center, São Paulo

All Listed Sponsors
lead

Latin American Cooperative Oncology Group

OTHER

NCT04947683 - Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil | Biotech Hunter | Biotech Hunter